In intensive care units, Acute Kidney Injury (AKI) is not an exception but a constant challenge. A recent study reported that AKI is a sudden episode of kidney failure frequently observed in critically ill patients (Nateghi Haredasht et al., 2023). For ICU teams, this means dealing with a rapidly evolving risk that, if recognized too late, leaves little room for intervention. The goal is not only to detect AKI, but to do so early enough to influence the clinical course.
In practice, timing is the key. Traditional detection methods, based on clinical markers such as serum creatinine and urine output, often reveal kidney damage only once it has already occurred (Tran et al., 2024). While indispensable, creatinine and urine output are late indicators. This has led to increasing interest in tools that can capture early warning signs from the routine data generated every day in the ICU.
This shift explains why there is now greater focus on prediction rather than simple detection. The same study highlights that early detection and prediction of AKI can improve outcomes through timely interventions (Tran et al., 2024).
In recent years, artificial intelligence models trained on electronic health records and laboratory results have enabled continuous risk assessment. Instead of a single one-time assessment at admission, these models provide an evolving picture that updates hour by hour, following the patient’s condition in real time. A large multicenter study demonstrated that an AI-based predictive model recalculates every hour the probability of developing stage 2–3 AKI using routinely collected clinical data (Alfieri et al., 2023).
The results were strong: the model achieved an AUROC of 0.884 in the internal test, 0.877 in the U.S. external cohort, and 0.911 in the Italian cohort. Importantly, across all datasets, predictions preceded clinical recognition by at least 14 hours (Alfieri et al., 2023). Clinically, this advance provides a valuable window to act, enabling timely interventions such as reviewing potentially nephrotoxic drugs, adjusting dosages, and intensifying urine output monitoring before AKI becomes evident. The study also emphasized that the software could be directly integrated into ICU information systems, supporting seamless implementation (Alfieri et al., 2023).
Predicting AKI onset is only the first step. The next challenge is identifying which episodes are unlikely to resolve within 72 hours (persistent stage 3 AKI). A study involving 7,759 patients developed and externally validated a real-time model for this purpose. Performance was high, with an AUROC of 0.94 in the U.S. cohort and 0.85 in the Italian cohort (Zappalà et al., 2024). Early recognition of these patients allows for more accurate risk stratification and better planning of renal replacement therapy (RRT).
In summary, predictive models provide clinicians with precious hours of decision-making advantage and help refine priorities, marking a shift in ICU practice. Artificial intelligence is emerging as an innovative support, capable of identifying high-risk patients before kidney injury becomes clinically detectable, thus enabling timely interventions (Tran et al., 2024). More than a technological add-on, this represents a new way of managing clinical time: acting earlier, preventing avoidable harm, and making the most of the data already available in the ICU.
If you would like to learn more about a tool already implemented in real-world intensive care settings, click here to discover the U-Care Renal Platform.